• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hong Kong Health Protection recommendations on management of close contacts of human infection with avian influenza - March 20, 2015 H7N9 H5N1 H10N8

sharon sanders

Editor-in-Chief & President
[TABLE="align: left, border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD="width: 553, colspan: 2, align: left"][FONT=Helvetica, Arial, Verdana, sans-serif]
spacer.gif
[/FONT][/TD]
[/TR]
[TR]
[TD="width: 85%, align: left"] [TABLE="border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD="class: featurebluetxt, width: 435, align: left"][FONT=Helvetica, Arial, Verdana, sans-serif]20 March 2015[/FONT][/TD]
[/TR]
[TR]
[TD="class: featurebluetxt, width: 435, align: left"][FONT=Helvetica, Arial, Verdana, sans-serif]
spacer.gif
[/FONT][/TD]
[/TR]
[TR]
[TD="class: featuretitletxt, width: 435, align: left"] [FONT=Helvetica, Arial, Verdana, sans-serif]Latest recommendations from SCEZD on management of close contacts of cases of human infection with avian influenza [/FONT]
[/TD]
[/TR]
[TR]
[TD="class: featurenormaltxt_en, width: 60%, align: left"] [FONT=Helvetica, Arial, Verdana, sans-serif] The Centre for Health Protection (CHP) of the Department of Health announced today (March 20) the latest recommendations by the Scientific Committee on Emerging and Zoonotic Diseases (SCEZD) on management of close contacts of cases of human infection with avian influenza.

Based on review of the recommendations on contact tracing for human infection with avian influenza cases by the World Health Organization, and experiences and practices of other health authorities, the SCEZD recommends

the CHP to continue to conduct contact tracing of contacts of confirmed human cases of avian influenza.


Antiviral prophylaxis with oseltamivir (tamiflu) should be given to the close contacts at an appropriate treatment dose for five days.

Medical surveillance is to be undertaken for 10 days after the last exposure, where the close contacts should report to CHP promptly if fever or any respiratory symptom develops.

Moreover, close contacts should wear a face mask for 10 days since last exposure to a confirmed case while the case was infectious. There are no restrictions for work or other daily activities during the surveillance period. If the close contacts are contraindicated / intolerant to or refuse antiviral prophylaxis with oseltamivir, they should be put under quarantine for 10 days since last exposure.

"The above recommendations are based on the most current scientific understanding of the risk of human-to-human transmission of avian influenza A (H7N9) virus, which also apply to human infections with other types of avian influenza viruses with low risk of human-to-human transmission, like avian influenza A (H5N1)," a spokesman for CHP explained.

The SCEZD notes that avian influenza viruses may change unpredictably, including its transmissibility and pathogenicity. It advises CHP to closely monitor the latest scientific development on avian influenza viruses and review the above recommendations if in future new scientific evidence suggests changes in the potential of human-to-human transmission and antiviral susceptibility.

The public may visit the CHP's pages about avian influenza below for more information:

* The avian influenza page (www.chp.gov.hk/en/view_content/24244.html);
* The weekly Avian Influenza Report (www.chp.gov.hk/en/view_content/3879.html); and
* Global statistics and affected areas of avian influenza (www.chp.gov.hk/files/pdf/global_statistics_avian_influenza_e.pdf).
[/FONT]
[FONT=Helvetica, Arial, Verdana, sans-serif]Ends/Friday, March 20, 2015[/FONT]


http://www.chp.gov.hk/en/view_content/38967.html

[/TD]
[/TR]
[/TABLE]

[/TD]
[/TR]
[/TABLE]
 
Back
Top Bottom